Cannabinoid formulations and delivery systems: Current and future options to treat pain
B Stella, F Baratta, C Della Pepa, S Arpicco, D Gastaldi… - Drugs, 2021 - Springer
The field of Cannabis sativa L. research for medical purposes has been rapidly advancing in
recent decades and a growing body of evidence suggests that phytocannabinoids are …
recent decades and a growing body of evidence suggests that phytocannabinoids are …
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events
Background Approximately 18% of patients with cancer use cannabis at one time as
palliation or treatment for their cancer. We performed a systematic review of randomized …
palliation or treatment for their cancer. We performed a systematic review of randomized …
Current challenges and opportunities for improved cannabidiol solubility
Cannabidiol (CBD), derived from the cannabis plant, has gained significant attention due to
its potential therapeutic benefits. However, one of the challenges associated with CBD …
its potential therapeutic benefits. However, one of the challenges associated with CBD …
[HTML][HTML] Traditional uses of Cannabis: An analysis of the CANNUSE database
Ethnopharmacological relevance Cannabis is one of the most versatile genera in terms of
plant use and has been exploited by humans for millennia. Nowadays, Cannabis is the …
plant use and has been exploited by humans for millennia. Nowadays, Cannabis is the …
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
RG Dos Santos, FS Guimarães… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Recent trials using cannabidiol (CBD) have shown that most acute and
prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects …
prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects …
Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study
K Kongkadee, W Wisuitiprot, K Ingkaninan… - Archives of Oral …, 2022 - Elsevier
Objective To evaluate the anti-inflammatory and gingival wound healing activities of
Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol (CBD). Design The cellular …
Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol (CBD). Design The cellular …
Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials
I Dykukha, R Malessa, U Essner, MA Überall - Pain Medicine, 2021 - academic.oup.com
Objective Pooled analysis of nabiximols and placebo in randomized controlled studies
(RCTs) of chronic neuropathic pain. Design Systematic review and meta-analysis. Methods …
(RCTs) of chronic neuropathic pain. Design Systematic review and meta-analysis. Methods …
[HTML][HTML] The impact of cannabidiol on psychiatric and medical conditions
T Oberbarnscheidt, NS Miller - Journal of clinical medicine …, 2020 - ncbi.nlm.nih.gov
Cannabidiol (CBD) is a substance chemically derived from Cannabis sativa and discussed
to be non-psychoactive. According to the FDA, marijuana is classified as a schedule I …
to be non-psychoactive. According to the FDA, marijuana is classified as a schedule I …
A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019
Abstract In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM)
report comprehensively evaluated the body of evidence regarding cannabis health effects …
report comprehensively evaluated the body of evidence regarding cannabis health effects …
Neuropathic pain in cancer: what are the current guidelines?
Opinion Statement Neuropathic cancer pain is experienced by 30–40% of patients with
cancer. It significantly reduces quality of life and overall wellbeing for patients living with and …
cancer. It significantly reduces quality of life and overall wellbeing for patients living with and …